Lista de obras - Shadia I. Jalal - Dominio Público Uruguay

24-Month Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab As First-Line Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer

article by Hossein Borghaei et al published 20 August 2018 in Journal of Thoracic Oncology

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier cancer research network LUN 14-179

artículo científico publicado en 2020

A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors

scientific article published on 16 April 2019

Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study

scientific article published on 06 August 2018

Acceptance and Commitment Therapy for Symptom Interference in Advanced Lung Cancer and Caregiver Distress: A Pilot Randomized Trial

scientific article published on 28 June 2019

Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

artículo científico publicado en 2015

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function

scientific article published on 17 April 2020

Barriers to mental health service use and preferences for addressing emotional concerns among lung cancer patients

artículo científico publicado en 2014

Blood-based tumor biomarkers in lung cancer for detection and treatment.

artículo científico publicado en 2017

Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors

artículo científico publicado en 2019

Brief Report: Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer

scientific article published on 28 September 2020

Carboplatin and Etoposide With or Without Palifosfamide in Untreated Extensive-Stage Small-Cell Lung Cancer: A Multicenter, Adaptive, Randomized Phase III Study (MATISSE).

artículo científico publicado en 2017

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

artículo científico publicado en 2016

Circulating tumor cell detection using a parallel flow micro-aperture chip system

artículo científico publicado en 2015

Concurrent Detection of Cellular and Molecular Cancer Markers Using an Immunomagnetic Flow System

artículo científico publicado en 2015

Coping Skills Practice and Symptom Change: A Secondary Analysis of a Pilot Telephone Symptom Management Intervention for Lung Cancer Patients and their Family Caregivers

artículo científico publicado en 2018

Coping with physical and psychological symptoms: a qualitative study of advanced lung cancer patients and their family caregivers

artículo científico publicado en 2014

DNA Repair: From Genome Maintenance to Biomarker and Therapeutic Target ⬇️

artículo científico publicado el 9 de septiembre de 2011

DNA repair in lung cancer: potential not yet reached.

artículo científico publicado en 2016

DNA repair targeted therapy: The past or future of cancer treatment?

artículo científico publicado en 2016

Development of a Symptom Management Intervention: Qualitative Feedback From Advanced Lung Cancer Patients and Their Family Caregivers

artículo científico publicado en 2016

Doppler fluctuation spectroscopy of intracellular dynamics in living tissue

artículo científico publicado en 2019

Economic and social changes among distressed family caregivers of lung cancer patients

artículo científico publicado en 2012

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Use for Subclassification and Genotyping of Lung Non-Small-Cell Carcinoma

artículo científico publicado en 2018

Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77.

artículo científico publicado en 2012

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

artículo científico publicado en 2018

Examining the effect of peer helping in a coping skills intervention: a randomized controlled trial for advanced gastrointestinal cancer patients and their family caregivers

Exploring a structural protein-drug interactome for new therapeutics in lung cancer

artículo científico publicado en 2014

Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair.

artículo científico publicado en 2014

Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?

artículo científico publicado en 2020

Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration

artículo científico

Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin

artículo científico publicado en 2011

Novel therapies in small cell lung cancer

artículo científico publicado en 2015

Outcomes of a novel intrathoracic esophagogastric anastomotic technique

scientific article published on 08 June 2018

Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the Hoosier Oncology Group ⬇️

artículo científico publicado el 1 de diciembre de 2010

Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies

scientific article published on 20 December 2019

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study

artículo científico publicado en 2019

Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H

scientific article published on 17 December 2018

Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study

artículo científico publicado en 2009

Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology Group

artículo científico publicado en 2009

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer

scientific article published on 11 September 2020

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors

artículo científico publicado en 2017

Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130.

artículo científico publicado en 2014

Pulmonary Langerhans cell histiocytosis masquerading as adenocarcinoma of the lung

Randomized Pilot Trial of a Telephone Symptom Management Intervention for Symptomatic Lung Cancer Patients and Their Family Caregivers

artículo científico publicado en 2016

Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma

artículo científico publicado en 2017

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial

artículo científico publicado en 2018

Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device

artículo científico publicado en 2017

Small Cell Lung Cancer

artículo científico publicado en 2016

Small-molecule binding sites to explore protein-protein interactions in the cancer proteome

artículo científico publicado en 2016

Social correlates of mental health in gastrointestinal cancer patients and their family caregivers: Exploring the role of loneliness

scientific article published on 17 September 2018

Spontaneous Pneumothoraces and Hemothoraces in Sarcomas

artículo científico publicado en 2017

Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer

scientific article published on 01 December 2017

Support service use and interest in support services among distressed family caregivers of lung cancer patients

artículo científico publicado en 2012

Support service use and interest in support services among lung cancer patients

scientific article published on 06 August 2013

The Case for Maintenance Pemetrexed Plus Bevacizumab

artículo científico publicado en 2020

The role of maintenance chemotherapy in advanced nonsmall cell lung cancer.

scientific article published on March 2009

Tissue dynamics spectroscopic imaging: functional imaging of heterogeneous cancer tissue

scientific article published on 01 September 2020

Treatment of clinical T2N0M0 esophageal cancer

artículo científico publicado en 2014

Lista de obras de Shadia I. Jalal

24-Month Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab As First-Line Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier cancer research network LUN 14-179

A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors

Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study

Acceptance and Commitment Therapy for Symptom Interference in Advanced Lung Cancer and Caregiver Distress: A Pilot Randomized Trial

Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function

Barriers to mental health service use and preferences for addressing emotional concerns among lung cancer patients

Blood-based tumor biomarkers in lung cancer for detection and treatment.

Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors

Brief Report: Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer

Carboplatin and Etoposide With or Without Palifosfamide in Untreated Extensive-Stage Small-Cell Lung Cancer: A Multicenter, Adaptive, Randomized Phase III Study (MATISSE).

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

Circulating tumor cell detection using a parallel flow micro-aperture chip system

Concurrent Detection of Cellular and Molecular Cancer Markers Using an Immunomagnetic Flow System

Coping Skills Practice and Symptom Change: A Secondary Analysis of a Pilot Telephone Symptom Management Intervention for Lung Cancer Patients and their Family Caregivers

Coping with physical and psychological symptoms: a qualitative study of advanced lung cancer patients and their family caregivers

DNA Repair: From Genome Maintenance to Biomarker and Therapeutic Target ⬇️

DNA repair in lung cancer: potential not yet reached.

DNA repair targeted therapy: The past or future of cancer treatment?

Development of a Symptom Management Intervention: Qualitative Feedback From Advanced Lung Cancer Patients and Their Family Caregivers

Doppler fluctuation spectroscopy of intracellular dynamics in living tissue

Economic and social changes among distressed family caregivers of lung cancer patients

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Use for Subclassification and Genotyping of Lung Non-Small-Cell Carcinoma

Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77.

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

Examining the effect of peer helping in a coping skills intervention: a randomized controlled trial for advanced gastrointestinal cancer patients and their family caregivers

Exploring a structural protein-drug interactome for new therapeutics in lung cancer

Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair.

Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?

Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration

Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin

Novel therapies in small cell lung cancer

Outcomes of a novel intrathoracic esophagogastric anastomotic technique

Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the Hoosier Oncology Group ⬇️

Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study

Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H

Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study

Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology Group

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors

Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130.

Pulmonary Langerhans cell histiocytosis masquerading as adenocarcinoma of the lung

Randomized Pilot Trial of a Telephone Symptom Management Intervention for Symptomatic Lung Cancer Patients and Their Family Caregivers

Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial

Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device

Small Cell Lung Cancer

Small-molecule binding sites to explore protein-protein interactions in the cancer proteome

Social correlates of mental health in gastrointestinal cancer patients and their family caregivers: Exploring the role of loneliness

Spontaneous Pneumothoraces and Hemothoraces in Sarcomas

Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer

Support service use and interest in support services among distressed family caregivers of lung cancer patients

Support service use and interest in support services among lung cancer patients

The Case for Maintenance Pemetrexed Plus Bevacizumab

The role of maintenance chemotherapy in advanced nonsmall cell lung cancer.

Tissue dynamics spectroscopic imaging: functional imaging of heterogeneous cancer tissue

Treatment of clinical T2N0M0 esophageal cancer